Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

cobicistat-darunavir

cobicistat-darunavir
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Prezcobix TABLET, ORAL 150 mg-800 mg    
Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

cobicistat-darunavir (Prezcobix)

  • 150 mg-800 mg tablet once Daily

cobicistat (Tybost) and darunavir (Prezista)

  • One 150 mg cobicistat tablet PLUS ONE 800 mg  darunavir tablet

Prezcobix is classified as non-formulary, not stocked. Interchange to individual components dispensed separately.

Reviewed: 26 May 2015 (Prezcobix)

Last updated: Dec. 19, 2017






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved